Insider Transactions in Q1 2024 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2024
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,551
-5.09%
|
$196,367
$17.55 P/Share
|
|
Mar 18
2024
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,449
-2.81%
|
$242,082
$18.23 P/Share
|
|
Feb 27
2024
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Indirect |
23,132
-1.91%
|
$462,640
$20.1 P/Share
|
|
Feb 27
2024
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
34,070
-12.42%
|
$681,400
$20.11 P/Share
|
|
Feb 26
2024
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Indirect |
3,900
-0.32%
|
$78,000
$20.06 P/Share
|
|
Feb 26
2024
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
24,555
-8.22%
|
$491,100
$20.07 P/Share
|
|
Jan 29
2024
|
Gilead Sciences Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
15,238,095
+33.64%
|
$319,999,995
$21.0 P/Share
|
|
Jan 23
2024
|
Carolyn C. Tang General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
26,700
+18.9%
|
-
|
|
Jan 23
2024
|
Alexander Azoy Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,850
+31.7%
|
-
|
|
Jan 23
2024
|
Juan C. Jaen President |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+10.49%
|
-
|
|
Jan 23
2024
|
Ii Robert C. Goeltz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,300
+22.56%
|
-
|
|
Jan 23
2024
|
Dimitry Sa Nuyten Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+22.01%
|
-
|
|
Jan 23
2024
|
Jennifer Jarrett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+11.8%
|
-
|
|
Jan 23
2024
|
Terry J Rosen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+2.46%
|
-
|
|
Jan 02
2024
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Indirect |
6,975
-0.57%
|
$139,500
$20.09 P/Share
|
|
Jan 02
2024
|
Ii Robert C. Goeltz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,004
-3.72%
|
$40,080
$20.0 P/Share
|